Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Concomitant granule cell neuronopathy in patients with natalizumab-associated PML.
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy.
Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
Glio-vascular modifications caused by Aquaporin-4 deletion in the mouse retina.
White Matter Injury in Ischemic Stroke.
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.
Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia.
Effect of the innate immune response on development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Natural antisense RNAs are involved in the regulation of CD45 expression in autoimmune diseases.
Acute cervical segmental denervation in neuromyelitis optica spectrum disorder.
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?
IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis.
Comparing statistical methods for removing seasonal variation from vitamin D measurements in case-control studies.
The relationship between fear of falling to spatiotemporal gait parameters measured by an instrumented treadmill in people with multiple sclerosis.
Acid-Sensing Ion Channels Contribute to Neurotoxicity.
Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classification.
The economic impact of multiple sclerosis in Australia in 2010.
Osteopontin in Immune-mediated Diseases.
Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".
Involvement of CD8(+) T Cells in Multiple Sclerosis.
Therapeutic Potential of the Modulation of Sphingosine 1 phosphate receptors.
Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
GABA: a new imaging biomarker of neurodegeneration in multiple sclerosis?
Contralateral recurrence of tumefactive demyelination.
Serial electrophysiological studies in a Guillain-Barré subtype with bilateral facial neuropathy.
Pages
« first
‹ previous
…
622
623
624
625
626
627
628
629
630
…
next ›
last »